In this episode of Cures & Capital, Dr. Sheila Gujrathi — biotech entrepreneur, investor, and former CEO of Gossamer Bio — shares her perspective on how to elevate female leaders and underrepresented voices in biopharma. She discusses lessons from her 25+ years leading companies and investments, and why inclusive leadership is key to innovation and value creation. We also dive into her book, The Mirror Effect, and her mission to inspire the next generation of women in biotech. Check out S...
All content for Cures & Capital is the property of Martin Slezak and Simon Birksø and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Cures & Capital, Dr. Sheila Gujrathi — biotech entrepreneur, investor, and former CEO of Gossamer Bio — shares her perspective on how to elevate female leaders and underrepresented voices in biopharma. She discusses lessons from her 25+ years leading companies and investments, and why inclusive leadership is key to innovation and value creation. We also dive into her book, The Mirror Effect, and her mission to inspire the next generation of women in biotech. Check out S...
Kelvin Stott on what it takes to fix pharma's broken business model
Cures & Capital
1 hour
9 months ago
Kelvin Stott on what it takes to fix pharma's broken business model
In this episode, Kelvin Stott talks about why might be pharma's business model broken and how can it be fixed, the declining ROI on drug R&D, better R&D portfolio decision making, raising the bar in pharma/biotech innovation and more. Kelvin Stott has over 20 years of diverse leadership experience in pharma R&D strategy and operations, drug discovery and development, portfolio management, strategy consulting, biotech start-ups and venture capital. Currently, he is the Found...
Cures & Capital
In this episode of Cures & Capital, Dr. Sheila Gujrathi — biotech entrepreneur, investor, and former CEO of Gossamer Bio — shares her perspective on how to elevate female leaders and underrepresented voices in biopharma. She discusses lessons from her 25+ years leading companies and investments, and why inclusive leadership is key to innovation and value creation. We also dive into her book, The Mirror Effect, and her mission to inspire the next generation of women in biotech. Check out S...
